Skip to main content
Premium Trial:

Request an Annual Quote

MWG Raises 3.1M in Share Offering

NEW YORK, May 14 (GenomeWeb News) -MWG Biotech announced today that it has raised €3.1 million in capital through a stock offering to institutional investors.

 

The stock was offered at €1.25 per share, and the total placement value was €3.88 million. The shares were placed by VEM Aktienbank.

 

MWG said that it plans to use the extra capital to finance the development of a new technology for making synthetic nucleic acids. The company said that with the new technology in place, it could reduce production costs for the molecules by 40 percent.

 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.